Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2 V Monteil, H Kwon, P Prado, A Hagelkrüys, RA Wimmer, M Stahl, ... Cell 181 (4), 905-913. e7, 2020 | 2252 | 2020 |
Somatic coding mutations in human induced pluripotent stem cells A Gore, Z Li, HL Fung, JE Young, S Agarwal, J Antosiewicz-Bourget, ... Nature 471 (7336), 63-67, 2011 | 1455 | 2011 |
Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2 A Giorgetti, N Montserrat, T Aasen, F Gonzalez, I Rodríguez-Pizà, ... Cell stem cell 5 (4), 353-357, 2009 | 510 | 2009 |
Human recombinant soluble ACE2 in severe COVID-19 A Zoufaly, M Poglitsch, JH Aberle, W Hoepler, T Seitz, M Traugott, A Grieb, ... The Lancet Respiratory Medicine 8 (11), 1154-1158, 2020 | 403 | 2020 |
Progressive degeneration of human neural stem cells caused by pathogenic LRRK2 GH Liu, J Qu, K Suzuki, E Nivet, M Li, N Montserrat, F Yi, X Xu, S Ruiz, ... Nature 491 (7425), 603-607, 2012 | 400 | 2012 |
Directed differentiation of human pluripotent cells to ureteric bud kidney progenitor-like cells Y Xia, E Nivet, I Sancho-Martinez, T Gallegos, K Suzuki, D Okamura, ... Nature cell biology 15 (12), 1507-1515, 2013 | 376 | 2013 |
Forty years of IVF C Niederberger, A Pellicer, J Cohen, DK Gardner, GD Palermo, ... Fertility and sterility 110 (2), 185-324. e5, 2018 | 319 | 2018 |
Selective elimination of mitochondrial mutations in the germline by genome editing P Reddy, A Ocampo, K Suzuki, J Luo, SR Bacman, SL Williams, ... Cell 161 (3), 459-469, 2015 | 305 | 2015 |
Tissue engineering by decellularization and 3D bioprinting E Garreta, R Oria, C Tarantino, M Pla-Roca, P Prado, F Fernandez-Aviles, ... Materials Today 20 (4), 166-178, 2017 | 273 | 2017 |
Active superelasticity in three-dimensional epithelia of controlled shape E Latorre, S Kale, L Casares, M Gómez-González, M Uroz, L Valon, ... Nature 563 (7730), 203-208, 2018 | 269 | 2018 |
Complete meiosis from human induced pluripotent stem cells C Eguizabal, N Montserrat, R Vassena, M Barragan, E Garreta, ... Stem cells 29 (8), 1186-1195, 2011 | 247 | 2011 |
Fine tuning the extracellular environment accelerates the derivation of kidney organoids from human pluripotent stem cells E Garreta, P Prado, C Tarantino, R Oria, L Fanlo, E Martí, D Zalvidea, ... Nature materials 18 (4), 397-405, 2019 | 227 | 2019 |
In vivo activation of a conserved microRNA program induces mammalian heart regeneration A Aguirre, N Montserrat, S Zacchigna, E Nivet, T Hishida, MN Krause, ... Cell stem cell 15 (5), 589-604, 2014 | 222 | 2014 |
Coordinated regulation of the GH/IGF system genes during refeeding in rainbow trout (Oncorhynchus mykiss) JC Gabillard, BB Kamangar, N Montserrat Journal of Endocrinology 191 (1), 15-24, 2006 | 220 | 2006 |
Identification of a specific reprogramming-associated epigenetic signature in human induced pluripotent stem cells S Ruiz, D Diep, A Gore, AD Panopoulos, N Montserrat, N Plongthongkum, ... Proceedings of the National Academy of Sciences 109 (40), 16196-16201, 2012 | 196 | 2012 |
Conversion of human fibroblasts to angioblast-like progenitor cells L Kurian, I Sancho-Martinez, E Nivet, A Aguirre, K Moon, C Pendaries, ... Nature methods 10 (1), 77-83, 2013 | 193 | 2013 |
Rethinking organoid technology through bioengineering E Garreta, RD Kamm, SM Chuva de Sousa Lopes, MA Lancaster, ... Nature materials 20 (2), 145-155, 2021 | 192 | 2021 |
ISSCR guidelines for stem cell research and clinical translation: the 2021 update R Lovell-Badge, E Anthony, RA Barker, T Bubela, AH Brivanlou, ... Stem cell reports 16 (6), 1398-1408, 2021 | 189 | 2021 |
Reprogramming of human fibroblasts to pluripotency with lineage specifiers N Montserrat, E Nivet, I Sancho-Martinez, T Hishida, S Kumar, L Miquel, ... Cell stem cell 13 (3), 341-350, 2013 | 165 | 2013 |
Hypoxia drives breast tumor malignancy through a TET–TNFα–p38–MAPK signaling axis MZ Wu, SF Chen, S Nieh, C Benner, LP Ger, CI Jan, L Ma, CH Chen, ... Cancer research 75 (18), 3912-3924, 2015 | 164 | 2015 |